Neuro Touch™

AI Wireless Neuropathy Device




Pre-Order Now for Section 179 Tax Deductions


Diabetic Peripheral Neuropathy

The Neuro Touch™ (NT) is an FDA Registered Wireless Neuropathy Tool that uses AI to Identifies, Measures, and Standardizes Peripheral Neuropathy Exams Using State-of-the-Art Technology. 

Digital Monofilament

Variable (((Vibrations)))

Hot/Cold Temperatures

Infrared Thermometry

Neuro Touch™ Provides AI-Powered Reports

Our AI-powered device enables you to efficiently store, manage, analyze and share test results online, on our secure cloud servers HIPAA Compliant server. It is imperative to educate medical providers on better testing methods with objective tools to improve patient outcomes that close gaps in care. The Neuro Touch™ meets the CMS Medicare Advantage Star Ratings. The clinical incentives for Primary Care follow recommendations by the American Diabetes Association (ADA) and identify peripheral neuropathy in people living with diabetes. Using the Neuro Touch™ with the traditional tools that are attached, can enhance clinical outcomes. 

Approximately 30 million Americans suffer from peripheral neuropathy, 60% suffer from diabetic neuropathy, and 40% suffer from other non-diabetic neuropathic complications. Diabetes mellitus, chemotherapy, long-term antibiotic treatment, and nutritional deficiency are all etiological factors that should allow testing. Although Distal Symmetric Polyneuropathy (DSPN) causes nerve damage to peripheral extremities including the hands, arms, legs, and feet. Utilizing an objective and functional tool that measures large fiber and small fiber nerves for all of the peripheral extremities can also change the mortality and morbidity of diabetic patients.

"It is imperative that we use our ability to measure quantitatively the different types of defects that occur in the disorder (DN), so the appropriate therapies can be targeted to specific nerve fiber types."

Aaron Vinik, MD, PhD, FCP, MACP, FACE, et al, Endocrinologist, Diabetic Neuropathies, February 5, 2018

Neuro Touch™ uses a proprietary Artificial Intelligence (AI) powered design that enables you to efficiently store, manage, analyze and share test results online and on our secure cloud servers. 

Key Features


1. Wireless Convenience: Streamlined and portable design for ease of use in any clinical setting. 

2. Multi-Parameter Screening: NT combines five different neuropathy screening tools into a single, portable device. This integration enhances diagnostic efficiency and accuracy.

3. AI-Powered Reports: The device leverages artificial intelligence for data management and analysis, providing healthcare professionals with detailed and actionable insights.

4. Portable and Lightweight: Weighing just 470 grams, NT is easy to handle and transport, making it suitable for use in various clinical settings.

5. Long Battery Life: The device can screen over 30-50 patients on a single charge, ensuring continuous operation during busy screening sessions.

6. Bluetooth Connectivity: Data can be transferred via Bluetooth to an Android app, facilitating seamless integration with electronic health records (EHRs).

7. Cloud-Based Report Generation: AI-generated reports can be accessed through a web portal enabling remote monitoring and analysis.

8. User-Friendly Interface: Designed with healthcare professionals in mind, the device features an intuitive interface that simplifies the screening process. 

Importance of Specificity

Diabetics that have lower-extremity amputations have lifespans that range between 40% mortality in 1-year, 65% mortality in 3-years, and 80% mortality in 5-years. Diabetic Neuropathy is a serious diabetes complication affecting as many as 50% of people who suffer from pain, and another 50% may be asymptomatic - who are at the highest risk of falls, ulcerations, and amputations. Nerve damage and poor circulation are the most common causes of diabetic foot problems. One of the most underdiagnosed and untreated parts of a comprehensive foot exam is checking the loss of protective sensation (LOPS) in the feet. The diabetic large nerve fiber dysfunction, as measured by vibration, predicts foot ulcerations, amputations, and mortality. 

(Painless) Diabetic large nerve fiber dysfunction as measured by vibration Predicts foot ulceration, amputation and mortality.

https://care.diabetesjournals.org/content/32/10/1896


The purpose of a comprehensive diabetic foot exam is to gather as much clinical data about the condition of a person's normal or abnormal condition in the feet of both large and small nerve fibers. A diabetic foot exam also checks people with diabetes for infection, injury, and bone abnormalities. However, over 99% of all medical providers use outdated and subjective tools (tuning fork, invented in 1711 or monofilaments, invented in 1938) to identify a progressive disease. Distal Symmetric Polyneuropathy (DSPN), a glove and stocking distribution, is the most common form of Diabetic Neuropathy (DN) and is recognized as the most troublesome complication of diabetes mellitus leading to the greatest morbidity and mortality, which accounts for the most amount of hospitalizations than all other diabetic complications combined and is responsible for up to 75% of non-traumatic amputations.

(Painful) Diabetic small fiber neuropathy can only be verified with thermal thresholds or skin biopsies.

Aaron Vinik, MD, Ph.D., Endocrinologist, Diabetic Neuropathies, February 5, 2018


The proper diagnosis of diabetic neuropathy should require tools to identify and measure the disorder quantitatively for the different abnormalities that occur to specific nerve fibers. Combining at least two different examinations (large and small fiber) will increase the sensitivity and specificity of detecting DPN. Currently, many medical providers are unaware of reimbursable tools that address both large fiber and small fiber neuropathy, both of which manifest in patients with diabetes. The Neuro Touch™ is the first FDA Cleared multi-objective tool with more than three measurements that identify both large and small nerve fibers in the upper and lower extremities.

Mechanism of Action

Skin is the largest organ of the body and helps regulate body temperatures and permits touch, heat, and cold sensations. The mechanism of action in identifying nerve fibers may be performed by testing the autonomic nervous system's sudomotor function using the sympathetic skin response (SSR). The SSR specifically tests sudomotor skin fibers that do not participate in thermoregulatory sweating. This methodology is currently performed using monofilaments and tuning forks and is recognized by multiple organizations around the U.S. including the American Diabetes Association (ADA) to diagnose autonomic dysfunction with polyneuropathies. Small fiber peripheral neuropathy primarily or exclusively affects the body, such as the skin and those that mediate pain and thermal sensation.

The sympathetic skin response is a simple, reproducible, and non-invasive test based on modifying the skin potential of peripheral nerves. Sympathetic skin response has been used to diagnose polyneuropathy, erectile dysfunction, central degenerative diseases, multiple sclerosis, brain infarction, reflex sympathetic dystrophies, spinal, and peripheral nerve lesions. The Neuro Touch™ is a modern tool that uses the SSR to help patients discriminate against variable temperature and vibration stimuli. 

Quantitative Sensory Testing (QST) and Sympathetic Skin Response tests (SSR) are distinct diagnostic procedures employed to assess the nervous system: QST focuses on evaluating sensory function by measuring the perception of stimuli, including touch, temperature, and pressure, commonly used in neurology to assess peripheral neuropathy; whereas SSR assesses the sympathetic nervous system's activity by measuring changes in skin conductance in response to stress or stimuli, often applied in neurology to evaluate autonomic nervous system function, with key differences lying in their respective focuses, stimuli application methods, and measurements. Multiple studies have proven the value of Quantitative Sensory Testing (QST) measures in the detection of subclinical neuropathy (small fiber neuropathy), the assessment of the progression of neuropathy, and the prediction of the risk of foot ulceration (117,129,130). These standardized measures of vibration and thermal thresholds also play an important role as primary efficacy endpoints in multicenter clinical trials. 

Do you want to improve your patient services but lack the financial resources to get started?  Click here to discuss potential collaborations and opportunities.

Clinical References (use dropdown)

NutriNerve®

The Best Supplement that Scientific Thinking Can Offer for Nerve Health.*

People with diabetes are living longer and healthier lives with fewer complications because of technological advances, earlier interventions, and, in some cases, all-natural supplements like Dr. A. Vinik MD PhD nerve health supplements. 

NutriNerve® is a proprietary formula created by the renowned Endocrinologist Dr. Aaron Vinik MD PhD. After many decades of scientific research in diabetic neuropathy, Dr. Vinik demonstrated that damaged nerves may be regenerated with the proper nutrients.


Click HERE for professional pricing.

Better Options